Company Monitoring Page for Alnylam

latest headlines for company on cafepharma

The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
Tags:
biotech, ONYX Pharmaceuticals, Celldex, Novavax, Puma Biotechnology, Endocyte, Alnylam, Bluebird Bio, Dyax, Medivation, Clovis Oncology, Achillion, Insmed, Arena Pharmaceuticals, Avanir, Receptos, Synergy Pharmaceuticals, ChemoCentryx, Idenix, MiMedx, Portola Pharmaceuticals
Alnylam Reports Positive Phase II Data for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR)
Yahoo/BusinessWire
Sun, 06/30/13 - 10:42 am
Tags:
ALN-TTR02, Alnylam, amyloidosis, TTR-mediated amyloidosis
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:07 am
Tags:
Zerenex, Xoma, Vical, Takeda, sovaprevir, Soluble Ferric Pyrophosphate, Rockwell Medical, Orexigen, MM-398, Merrimack Pharmaceuticals, MannKind, Keryx, GTx, GSK, gevokizumab, enobosarm, Coronado Biosciences, Contrave, CNDO-201, clinical trials, ChemoCentryx, CCX140, Biodel, BIOD-123, Amigal, Amicus Therapeutics, Alnylam, ALN-TTR02, Allovectin, Afrezza, Achillion, ACH-3102
Alnylam announces proof-of-concept data from RNAi program
Yahoo/Fly on the Wall
Fri, 05/17/13 - 11:28 am
Tags:
Alnylam, RNAi
Alnylam takes smaller 1Q loss on lower costs
Yahoo/AP
Tue, 05/7/13 - 11:41 am
Tags:
Alnylam, earnings
Is RNA Drug Development Coming of Age?
Motley Fool
Sat, 04/13/13 - 11:27 am
Tags:
Sarepta Therapeutics, Isis Pharmaceuticals, Alnylam
Investors Seeing Huge Potential In RNA Drug Developers
Seeking Alpha
Fri, 03/8/13 - 11:17 am
Tags:
Sarepta, RXi Pharmaceuticals, OPKO, Alnylam
Loss Widens at Alnylam, Sales Fall
Yahoo/Zacks
Fri, 02/8/13 - 12:02 pm
Tags:
Alnylam, earnings
The Medicines Co., Alnylam form strategic alliance to develop RNAi Therapeutics
Yahoo/Fly on the Wall
Mon, 02/4/13 - 12:14 pm
Tags:
RNAi, Alnylam, Medicines Company
Alnylam: Rally On No News Leaves Room For Downside
Seeking Alpha
Thu, 01/24/13 - 10:35 am
Tags:
Alnylam, Isis Pharmaceuticals
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Tags:
Alnylam, Regulus, Isis Pharmaceuticals, SynaGeva BioPharma, Sarepta Therapeutics, Onyx, Celgene, Millennium, Takeda, Ariad Pharmaceuticals, Pharmacyclics, Astex
Better Than Lipitor! Higher Sales?
Motley Fool
Tue, 01/1/13 - 11:53 am
Tags:
Pfizer, Lipitor, Juxtapid, Aegerion, Kynamro, Sanofi, Isis Pharmaceuticals, Regeneron, Alnylam, PCSK9 inhibitors
When Compared To Isis, Alnylam's Valuation Does Not Make Sense
Seeking Alpha
Wed, 12/19/12 - 01:32 pm
Tags:
Isis Pharmaceuticals, Alnylam
2 Biotech Stocks To Consider This Week In The Wake Of Trial Data
Seeking Alpha
Thu, 12/13/12 - 11:33 am
Tags:
Celldex, Alnylam, rindopepimut, ALN-TTR02, RNAi
Alnylam Presents New Pre-clinical Data on RNAi Therapeutics for the Treatment of Hemoglobinopathies at 54th American Society of Hematology (ASH) Annual Meeting
Yahoo/BusinessWire
Sat, 12/8/12 - 11:18 am
Tags:
Alnylam, β-thalassemia
Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., and Cytonet Set to Speak on Conducting Effective Orphan Drug Research
CP Wire
Fri, 11/16/12 - 10:27 am
Tags:
Alnylam, Cytonet, Biomarin, orphan drugs
Alnylam: No Approved Drugs, No Promising Candidates, No Justification For $1 Billion Valuation
Seeking Alpha
Thu, 11/15/12 - 11:32 am
Tags:
Alnylam
Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia
Yahoo
Mon, 10/22/12 - 10:19 am
Tags:
Alnylam, Genzyme, RNAi, Asia
Alnylam-ISIS Venture Prices IPO
Yahoo/Zacks
Sat, 10/6/12 - 11:50 am
Tags:
Alnylam, Isis Pharmaceuticals
Isis Pharmaceuticals to receive $1.4 million from Alnylam
Yahoo
Tue, 08/28/12 - 12:25 pm
Tags:
Isis Pharmaceuticals, Alnylam

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.